Skip to main content

Reese Consumer Health Acquires Topical Pain Relief Brand Australian Dream

Acquisition expands Reese’s consumer health portfolio and extends its reach across retail and e-commerce

Australian Dream Back Pain and Arthritis Pain Relief Cream

Australian Dream Back Pain and Arthritis Pain Relief Cream
Australian Dream Back Pain and Arthritis Pain Relief Cream

Australian Dream Arthritis Pain Relief Cream

Australian Dream Arthritis Pain Relief Cream
Australian Dream Arthritis Pain Relief Cream

Australian Dream Logo

Australian Dream Logo
Australian Dream Logo

Australian Dream Back Pain Relief Cream

Australian Dream Back Pain Relief Cream
Australian Dream Back Pain Relief Cream

CLEVELAND, Aug. 13, 2026 (GLOBE NEWSWIRE) — Reese Consumer Health today announced the acquisition of Australian Dream, a nationally recognized consumer health brand specializing in topical pain relief for arthritis, muscle, and joint discomfort.

The acquisition strengthens Reese’s presence in the OTC pain relief category and adds an established brand with a loyal consumer following to its growing health and wellness portfolio. Reese plans to use its category expertise, consumer insights, and longstanding retail relationships to expand Australian Dream’s reach across retail, e-commerce and direct-to-consumer channels.

“Australian Dream brings strong brand heritage, a meaningful point of difference, and a loyal consumer base—exactly the kind of foundation we believe can support significant growth,” said Jeff Reese, President of Reese Consumer Health. “By combining Australian Dream’s established consumer base with Reese’s capabilities in innovation, marketing, and retail execution, we see a significant opportunity for continued growth.”

The acquisition also expands the ways Reese can engage directly with consumers and learn from how they discover, purchase, and use health and wellness products.

“Adding Australian Dream strengthens not only our brand portfolio, but our ability to serve both consumers and our retail partners,” said Joseph Juliano, Vice President of Sales/Marketing/New Business Development. “More products and more touchpoints across both retail and e-commerce give us a better insight into what consumers are looking and how shopping behavior is changing. We can bring those insights back to our retail partners to identify opportunities, develop the right products and get them to market faster.”

The announcement comes as Reese prepares to meet with retailers and industry partners at the NACDS Total Store Expo in Boston this weekend (Booth #1438Q). The company continues to invest in expanding its consumer reach and capabilities, including its first entry into international markets last fall and a new Cleveland facility planned for 2027.

About Reese Consumer Health
Founded in 1907 and headquartered in Cleveland, Ohio, Reese Consumer Health Corporation is a privately held manufacturer of branded and private label products selling to national and regional chains, food and grocery, drug wholesalers, co-ops, and independent pharmacies.

Media Contact:
Andrea LePain
andrea@emediajunction.com
617-894-1153

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/e159d145-2c89-4b98-a197-37782645896d
https://www.globenewswire.com/NewsRoom/AttachmentNg/b5b0472f-e140-4b88-9053-28705bf951f9
https://www.globenewswire.com/NewsRoom/AttachmentNg/a4253281-a727-46ae-8b0f-580f1b3264fc
https://www.globenewswire.com/NewsRoom/AttachmentNg/bdef110a-742f-4b74-ad73-4a08f54612ec

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.